42
Participants
Start Date
August 16, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Conversion from IR Tacrolimus to XR Tacrolimus
All participants will be consented to the study on IR Tacrolimus. After their baseline visit, they will be converted to XR Tacrolimus
RECRUITING
Loyola University Medical Center, Maywood
Collaborators (1)
Veloxis Pharmaceuticals
INDUSTRY
Loyola University
OTHER